MedCity News

DECEMBER 25, 2023

Executives at LRVHealth expect to see a continued focus on generative AI, increased enrollment in Medicare Advantage and more in 2024.

Healthcare 324

Healthcare Healthcare 324

MedCity News

NOVEMBER 1, 2024

The post Heard at HLTH 2024 Part 2: Insights from Innovative Healthcare Executives appeared first on MedCity News. Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.

Healthcare 299

Healthcare Healthcare 299

MedCity News

JANUARY 30, 2024

A preview of ViVE 2024 offers a sneak peek at the agenda and how the Payer and Provider Connect meeting platform initiatives have been revamped to maximize the quantity and quality of meeting for healthcare executives.

Healthcare 306

Healthcare Healthcare 306

MedCity News

NOVEMBER 25, 2024

Updated schema requirements are easy to mix up — here are a few simple solutions The post Common MRF Mistakes Hospitals Are Making in 2024 appeared first on MedCity News.

288

288

MedCity News

SEPTEMBER 4, 2024

The post How Have Hospitals Fared Financially So Far in 2024? Health systems’ financial results suggest the start of sustained recovery, but persistent challenges remain, including rising expenses and less-than-ideal reimbursement rates from payers. appeared first on MedCity News.

298

298

MedCity News

JANUARY 2, 2024

A recent Deloitte report found that improving health equity is a top-10 goal for 83% of life sciences and healthcare C-suite executives in 2024. The report also laid out factors that will likely influence health equity in 2024, including AI.

Healthcare 338

Healthcare Healthcare 338

MedCity News

DECEMBER 10, 2023

Deloitte released a report predicting the key trends that will shape the healthcare landscape in 2024. Some of them include hospital M&A, health systems outsourcing departments and the increasing adoption of generative AI tools.

Healthcare 316

Healthcare Healthcare 316

MedCity News

JANUARY 8, 2025

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO markets return to normal levels.

Biopharma 311

Biopharma Medicine Marketing FDA 311

MedCity News

DECEMBER 3, 2023

The top three areas of concern for employers in 2024 include rising healthcare costs, mental health challenges and cancer care, according to a recent report from Business Group on Health.

Healthcare 320

Healthcare Healthcare 320

MedCity News

APRIL 18, 2024

Q1 2024 saw a significant rise in the number of hospital M&A deals compared to the past three Q1s. The post Hospital M&A Activity in 2024: What to Expect appeared first on MedCity News. The post Hospital M&A Activity in 2024: What to Expect appeared first on MedCity News.

Healthcare 305

Healthcare Healthcare 305

MedCity News

FEBRUARY 26, 2024

At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration.

336

336

MedCity News

DECEMBER 20, 2023

Healthcare’s share of the global PE and VC deal count will likely continue decreasing in 2024, according to a new Pitchbook report. The report also predicted that generative AI and surgical robotics will continue to be hot areas of interest for investors, and that there will be at least three digital health IPOs next year.

Healthcare 321

Healthcare Healthcare 321

MedCity News

DECEMBER 29, 2023

There are three key trends for the healthcare industry to follow in 2024, including the rise of AI, increasing cost pressures and M&A activity, according to West Monroe.

Healthcare 325

Healthcare Healthcare 325

MedCity News

JANUARY 14, 2025

Morgan Healthcare Conference, Lilly CEO David Ricks explained why the company revised downward its projections for fourth quarter 2024 revenue. Revenue for the blockbuster Eli Lilly drugs Mounjaro and Zepbound continues to grow, but not as much as expected. At the J.P.

Sales 290

Sales Healthcare Healthcare Biopharma 290

MedCity News

SEPTEMBER 8, 2023

per employee on average in 2024, new data from Mercer shows. Employers expect health benefit costs to increase 5.4% This is due to inflationary pressures and health system consolidation.

Healthcare 312

Healthcare Healthcare 312

MedCity News

FEBRUARY 1, 2024

Here are 5 healthcare marketing trends to pay attention to in 2024. To meet evolving consumer expectations, providers must have a strong digital marketing strategy and user experience online.

Retail 306

Retail Marketing Healthcare Healthcare 306

MedCity News

JANUARY 7, 2024

A recent KPMG report laid out several tailwinds and headwinds for payers in 2024. Payers’ tailwinds include reduced recession worries, while their headwinds include Medicare Advantage scrutiny.

290

290

Fierce Pharma

DECEMBER 22, 2023

And it is with cautious optimism that industry watchers see the trend continuing in 2024. . | Even with the Federal Trade Commission keeping a watchful eye on the biopharma industry and the economic landscape giving some players pause, mergers and acquisitions are back on the rise.

Biopharma 349

Biopharma 349

MedCity News

NOVEMBER 6, 2023

About half (47%) of nonelderly uninsured veterans will be eligible for Medicaid or subsidies through the ACA Marketplace in 2024, according to a new report from the Urban Institute.

299

299

MedCity News

FEBRUARY 21, 2024

Mari Savickis, Vice President of Public Policy with CHIME, will be moderating a panel discussion as part of the Cybersecurity Pavilion at the ViVE 2024 event in Los Angeles, scheduled for February 25-28. She said her organization anticipates several developments addressing cybersecurity this year.

Healthcare 305

Healthcare Healthcare 305

MedCity News

JUNE 13, 2025

The agreement follows a 2024 licensing agreement that granted AstraZeneca rights to an oral CSPC drug candidate in development for a metabolic disorder. The post AstraZeneca Turns to CSPC Pharma Again, Putting Up $110M to Start Multi-Drug R&D Pact appeared first on MedCity News.

Pharma 235

Pharma Pharmaceutical Medical Biopharma 235

Fierce Pharma

JULY 30, 2024

For the first time since its sales peaked during the pandemic, Pfizer registered year-over-year revenue growth during the second quarter of 2024. For more than a year after Pfizer’s COVID product sales peaked at the end of 2022, the company’s quarterly revenues showed year-over-year declines. |

Sales 296

Sales 296

Fierce Pharma

OCTOBER 29, 2024

As the 2024 U.S. This week on "The Top Line," we explore how each presidential candidate’s approach to drug pricing could shape future policy.

246

246

MedCity News

FEBRUARY 12, 2024

The Payer Insights Program at ViVE 2024, in partnership with MedCity News, kicks off day one at the event. This new immersive program will focus on the impact of rising healthcare costs, recent regulatory changes, and innovative payer solutions for optimizing data insights, minimizing costs, and expanding access to care.

Healthcare 290

Healthcare Healthcare 290

Fierce Pharma

APRIL 1, 2024

The two most influential proxy advisory firms are rallying investors to vote against the 2024 pay proposal for Soriot at the company’s annual general meeting this month. Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again. Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again.

304

304

MedCity News

NOVEMBER 29, 2023

in 2024, according to a new report from Willis Towers Watson. Globally, health benefit costs are expected to increase 9.9% This is a slightly slower pace than in 2023, which saw a record-high increase of 10.7%.

Healthcare 299

Healthcare Healthcare 299

MedCity News

JANUARY 18, 2024

He predicted that the ability to achieve profitability will be much more important in 2024 than it has been in the past four years or so. This year’s digital health fundraising environment requires startups to focus more on their unit economics and pathway to profitability, according to Ian Wijaya, managing director at Lazard.

Management 298

Management 298

Fierce Pharma

JANUARY 8, 2024

In it’s annual Firepower report, EY says the biopharma industry enters 2024 with the capability and motivation to increase M&A activity. The late surge of activity in 2023 also bodes well for a 2024 uptick, the group said. Morgan Healthcare Conference. |

Prospecting 300

Prospecting Biopharma Pharma Healthcare 300

MedCity News

DECEMBER 12, 2023

Zocdoc Founder and CEO Oliver Kharraz gave five predictions about how patient preferences will evolve in 2024. Some of them include Americans increasingly seeking cash-pay care options and an uptick in patients seeking mental health appointments before and after the presidential election.

Patients 298

Patients 298

PharmaVoice

OCTOBER 8, 2024

This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.

363

363

Fierce Pharma

OCTOBER 29, 2024

As expected, Novartis’ radioligand therapy Pluvicto crossed the blockbuster sales threshold with one quarter still left of 2024. Novartis didn't use a priority review voucher for Pluvicto's key application in an earlier treatment setting of prostate cancer.

FDA 296

FDA Sales 296

MedCity News

JANUARY 8, 2024

Medicare Advantage patients without a primary care physician are perhaps the greatest risk to health plans in 2024. Health plans must adopt best practices to reach and engage MA patients, especially those with multiple, complex conditions. Here are six best practices to consider.

Physicians 289

Physicians Patients 289

MedCity News

FEBRUARY 14, 2024

2024 presents an exciting yet challenging landscape for global pharma marketers.

Marketing 288

Marketing Pharma Pharmaceutical Patients 288

Fierce Pharma

MARCH 27, 2024

WuXi Biologics stays the course with positive 2024 outlook as national security crackdown threatens business in US fkansteiner Wed, 03/27/2024 - 13:12

287

287

MedCity News

MAY 2, 2024

Where we’ve been, where we’re going, and how healthcare organizations can protect themselves from privacy risks caused by the Meta pixel and other third-party trackers The post The Rising Stakes of Healthcare Data Privacy in 2024: The Need for Practical Guidance appeared first on MedCity News.

Healthcare 303

Healthcare Healthcare 303

MedCity News

NOVEMBER 9, 2023

In total, there are 3,959 Medicare Advantage plans being offered for individual enrollment in 2024, a 1% decrease from 2023, according to a new report from KFF.

290

290